Vaccines and Related Biological Products Advisory Committee

Vaccines and Related Biological Products Advisory Committee
Meeting on February 28, 2012 between approximately 8:00 a.m. and 4:00 p.m (Day 1 of 2)

Agenda: On February 28, 2012, the committee will hear an overview of the research program in the Laboratory of Mycobacterial Diseases and Cellular Immunology, Division of Bacterial, Parasitic and Allergenic Products, Office of Vaccines Research and Review, Center of Biologics Evaluation and Research, FDA. The committee will then discuss and make recommendations on the selection of strains to be included in the influenza virus vaccine for the 2012-2013 influenza season. The committee will also hear an update on Pandemic Influenza Surveillance.